Instructor:
David Lim
Product ID: 703899
Why Should You Attend:
Fraud in medical research has a long, documented history. This webinar will discuss fraud in medical research to greatly improve attendees’ awareness about recent fraud in medical study and research. In particular, it is intended to help industry understand ethical and legal requirements when conducting medical research. The speaker will discuss key issues from recent cases of fraud in medical research and clinical trials.
The speaker will also share what should be done to properly address and rather prevent fraud in medical/clinical research and study including Dos and Don’ts. At the end of the webinar, participants will become familiar with the issues in fraud so that you can proactively identify, address and prevent fraud in medical/clinical research.
Learning Objectives:
Areas Covered in the Webinar:
Who Will Benefit:
This webinar will benefit those working with global pharmaceuticals, medical device and IVDs, healthcare industry, compliance consulting firms, health authorities, and compliance, regulatory, marketing and sales professionals.
Dr. David Lim, Ph.D., RAC, ASQ-CQA, is president and principal of Regulatory Doctor. He frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, he developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past eight years. Dr. Lim provides his feedback to regulatory agencies (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. He contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. He serves as a member of the Advisory Board for Inspection Insider published by FDA News.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
+1-888-717-2436
6201 America Center Drive Suite 240, San Jose, CA 95002, USA
Copyright © 2023 ComplianceOnline.com Our Policies: Terms of use | Privacy
PAYMENT METHOD: 100% Secure Transaction